CTAS vs VRNA

Comparison between Cintas Corporation (CTAS, Company) and Verona Pharma Plc (VRNA, Company).

CTAS is from the Industrials sector, while VRNA is from the Healthcare sector.

5-Year PerformanceVRNA has outperformed CTAS, delivering a return of +77.1% compared to +16.4%

CTAS vs VRNA - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	CTAS(COMPANY)	VRNA(COMPANY)
Market Cap	$77B	$78B
Max Drawdown	67.75%	89.71%
Sharpe Ratio	-0.46	2.69
5Y Beta	0.56	N/A
Industry	Specialty Business Services	Biotechnology
P/E Ratio	39.86	-852.67
Forward P/E	36.90	N/A
PEG Ratio	4.15	N/A
Dividend Yield	0.89%	N/A
5Y Dividends CAGR	11.82%	N/A
5Y EPS CAGR	15.38%	N/A
Debt to Equity	55.48%	87.12%
Free Cash Flow Yield	2.33%	-0.09%
P/S Ratio	6.98	350.73
P/B Ratio	15.40	279.39

Market Cap

CTAS

$77B

Winner

VRNA

$78B

Max Drawdown

Winner

CTAS

67.75%

VRNA

89.71%

Sharpe Ratio

CTAS

-0.46

Winner

VRNA

2.69

5Y Beta

CTAS

0.56

VRNA

N/A

Industry

CTAS

Specialty Business Services

VRNA

Biotechnology

P/E Ratio

CTAS

39.86

Winner

VRNA

-852.67

Forward P/E

CTAS

36.90

VRNA

N/A

PEG Ratio

CTAS

4.15

VRNA

N/A

Dividend Yield

CTAS

0.89%

VRNA

N/A

5Y Dividends CAGR

CTAS

11.82%

VRNA

N/A

5Y EPS CAGR

CTAS

15.38%

VRNA

N/A

Debt to Equity

Winner

CTAS

55.48%

VRNA

87.12%

Free Cash Flow Yield

Winner

CTAS

2.33%

VRNA

-0.09%

P/S Ratio

Winner

CTAS

6.98

VRNA

350.73

P/B Ratio

Winner

CTAS

15.40

VRNA

279.39

CTAS vs VRNA - Historical Returns

Returns include dividend reinvestment.

Period	CTAS	VRNA
1 month	+18.27%	+0.57%
3 months	+14.01%	+17.23%
6 months	+3.07%	+96.89%
1 year	-8.59%	+233.57%
5 years(CAGR)	+16.45%	+77.09%
10 years(CAGR)	+23.58%	+27.76%
Max(CAGR)	+13.14%	+27.76%

Winner

CTAS

+18.27%

VRNA

+0.57%

CTAS

+14.01%

Winner

VRNA

+17.23%

CTAS

+3.07%

Winner

VRNA

+96.89%

CTAS

-8.59%

Winner

VRNA

+233.57%

5Y(CAGR)

CTAS

+16.45%

Winner

VRNA

+77.09%

10Y(CAGR)

CTAS

+23.58%

Winner

VRNA

+27.76%

Max(CAGR)

CTAS

+13.14%

Winner

VRNA

+27.76%

CTAS vs VRNA - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	CTAS	VRNA
2026	+8.94%	N/A
2025	+4.13%	+121.80%
2024	+24.46%	+146.89%
2023	+35.60%	-18.79%
2022	+7.60%	+275.43%
2021	+30.13%	-5.35%
2020	+31.88%	+23.35%
2019	+62.22%	-40.41%
2018	+8.31%	-21.80%
2017	+35.46%	-12.07%
2016	+32.58%	N/A
2015	+17.39%	N/A
2014	+36.02%	N/A
2013	+43.96%	N/A
2012	+17.86%	N/A
2011	+26.66%	N/A
2010	+9.94%	N/A
2009	+11.53%	N/A
2008	-27.16%	N/A
2007	-16.06%	N/A
2006	-3.44%	N/A
2005	-4.02%	N/A
2004	-11.61%	N/A
2003	+7.44%	N/A
2002	-5.38%	N/A
2001	-4.28%	N/A
2000	+53.86%	N/A
1999	-12.73%	N/A

CTAS vs VRNA Drawdown Comparison

The maximum drawdown for CTAS was -65.30%, occurring on Mar 9, 2009. Recovery took 2829 trading sessions.

The maximum drawdown for VRNA was -89.71%, occurring on Mar 18, 2020. Recovery took 1189 trading sessions.

The current CTAS drawdown is -11.13%.

Rank	CTAS	VRNA
#1	-65.30% May 14, 2002 - Aug 8, 2013	-89.71% Apr 4, 2018 - Dec 21, 2022
#2	-48.38% Feb 19, 2020 - Jul 29, 2020	-56.07% Dec 30, 2022 - Aug 13, 2024
#3	-39.89% Nov 1, 1999 - Apr 4, 2000	-36.28% Sep 11, 2017 - Mar 15, 2018
#4	-36.22% Dec 26, 2000 - May 7, 2002	-29.89% May 23, 2017 - Sep 7, 2017
#5	-27.67% Jun 6, 2025 - May 13, 2026	-22.59% Feb 28, 2025 - Apr 29, 2025
#6	-27.09% Sep 6, 2018 - Apr 24, 2019	-13.51% Apr 29, 2025 - May 20, 2025
#7	-23.85% Dec 10, 2021 - Nov 22, 2022	-12.37% Nov 11, 2024 - Nov 27, 2024
#8	-23.77% Jun 2, 2000 - Nov 7, 2000	-10.66% Jun 24, 2025 - Jul 9, 2025
#9	-19.60% Nov 26, 2024 - May 27, 2025	-10.54% Mar 26, 2018 - Apr 4, 2018
#10	-16.42% Apr 4, 2000 - Apr 25, 2000	-8.78% Jan 7, 2025 - Jan 15, 2025
#11	-13.75% Dec 1, 2015 - May 24, 2016	-8.36% Sep 16, 2024 - Oct 3, 2024
#12	-13.73% Nov 27, 2000 - Dec 26, 2000	-8.20% Feb 21, 2025 - Feb 28, 2025
#13	-13.71% Nov 16, 2020 - Jun 22, 2021	-7.93% Mar 20, 2018 - Mar 26, 2018
#14	-12.80% Sep 6, 2016 - Dec 5, 2016	-7.47% Dec 27, 2022 - Dec 29, 2022
#15	-12.41% May 16, 2000 - May 30, 2000	-7.07% Aug 21, 2024 - Sep 10, 2024